483
Salil U. Nadkarni, DOSalil U. Nadkarni, DO – FDA 483, Sep 24, 2021
Record Details
An FDA inspection of Salil U. Nadkarni, DO, a clinical investigator in Los Angeles, CA, revealed a significant deviation from the investigational plan. The firm failed to ensure subjects met the required compliance for completing headache diaries during screening, impacting subject eligibility for a clinical trial. This indicates a failure to conduct the investigation in accordance with the protocol.
View Company Profile
ID · a5889bb1-6271-4fc5-9d54-b074deb7dddb
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.